⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19100153 | 0.92 | — | — | |
| SCHEMBL28076178 | 0.89 | — | — | |
| SCHEMBL1059967 | 0.81 | — | — | |
| SCHEMBL8207346 | 0.69 | — | — | |
| SCHEMBL22804154 | 0.69 | — | — | |
| SCHEMBL7390 | 0.69 | — | — | |
| SCHEMBL9331560 | 0.65 | — | — | |
| SCHEMBL7129634 | 0.65 | — | — | |
| SCHEMBL6342933 | 0.65 | — | — | |
| SCHEMBL7570146 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143408-B2 | N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2010-06-03 | — | — | US | claimed |
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | claimed |
| WO-2024143336-A1 | HYDRAZIDE COMPOUND AND AGRICULTURAL/HORTICULTURAL BACTERICIDAL AGENT | 日本曹達株式会社 | 2024-07-04 | — | — | WO | disclosed |
| EP-4371979-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| CN-117693500-A | Carboxamide derivative and agricultural/horticultural plant disease control agent | 组合化学工业株式会社 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023132369-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT | 中外製薬株式会社 | 2023-07-13 | — | — | WO | disclosed |
| WO-2023286855-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | クミアイ化学工業株式会社 | 2023-01-19 | — | — | WO | disclosed |
| US-20210346337-A1 | ANTICANCER ROCAGLAMIDE DERIVATIVES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-11-11 | — | — | US | disclosed |
| EP-3863625-A1 | ANTICANCER ROCAGLAMIDE DERIVATIVES | The Research Institute at Nationwide Children's Hospital (US) | 2021-08-18 | — | — | EP | disclosed |
| CN-106554382-B | Application in nucleoside phosphoramidite class compound and preparation method thereof and drug | 四川科伦博泰生物医药股份有限公司 | 2019-12-03 | — | — | CN | disclosed |
| EP-1569928-A1 | THERAPEUTIC COMPOUNDS AND METHODS | The Government of the State of Sarawak, Malaysia (MY) | 2005-09-07 | — | — | EP | disclosed |
| EP-1303520-A4 | THERAPEUTIC COMPOUNDS AND METHODS | GOVERNMENT OF THE STATE OF SAR (MY) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004041812-A1 | THERAPEUTIC COMPOUNDS AND METHODS | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2004-05-21 | — | — | WO | disclosed |
| US-6710075-B2 | COMPOUNDS HAVING A CYCLOPENTABENZOFURAN CORE SHOWN TO EXHIBIT POTENT CYTOTOXIC AND CYTOSTATIC EFFECTS ON CANCER CELL GROWTH AND VIABILITY | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2004-03-23 | — | — | US | disclosed |
| US-20030181514-A1 | Therapeutic compounds and methods | GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2003-09-25 | — | — | US | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| EP-1303520-A1 | THERAPEUTIC COMPOUNDS AND METHODS | The Government of the State of Sarawak, Malaysia (MY) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002002566-A1 | THERAPEUTIC COMPOUNDS AND METHODS | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2002-01-10 | — | — | WO | disclosed |